Table of Contents Table of Contents
Previous Page  285 / 604 Next Page
Information
Show Menu
Previous Page 285 / 604 Next Page
Page Background

Conclusion

Chemotherapy for

GCT, lymphoma

?breast, SCLC,

??alk+ve NSCLC, b-raf+ve melanoma

WBRT

RPA I/II

BSC

RPA III